Amanda Michelle Malone - Net Worth and Insider Trading

Amanda Michelle Malone Net Worth

The estimated net worth of Amanda Michelle Malone is at least $146,400 dollars as of 2024-11-13. Amanda Michelle Malone is the Senior Officer of Eupraxia Pharmaceuticals Inc and owns about 36,600 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) stock worth over $146,400. Details can be seen in Amanda Michelle Malone's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amanda Michelle Malone has not made any transactions after 2023-03-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Amanda Michelle Malone

Amanda Michelle Malone Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amanda Michelle Malone owns 1 companies in total, including Eupraxia Pharmaceuticals Inc (TSX:EPRX) .

Click here to see the complete history of Amanda Michelle Malone’s form 4 insider trades.

Insider Ownership Summary of Amanda Michelle Malone

Ticker	Comapny	Transaction Date	Type of Owner
TSX:EPRX	Eupraxia Pharmaceuticals Inc	2023-03-31	Senior Officer

Amanda Michelle Malone Latest Holdings Summary

Amanda Michelle Malone currently owns a total of 1 stock. Amanda Michelle Malone owns 36,600 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) as of March 31, 2023, with a value of $146,400.

Latest Holdings of Amanda Michelle Malone

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TSX:EPRX	Eupraxia Pharmaceuticals Inc	2023-03-31	36,600	4.00	146,400

Holding Weightings of Amanda Michelle Malone

Amanda Michelle Malone Form 4 Trading Tracker

According to the SEC Form 4 filings, Amanda Michelle Malone has made a total of 7 transactions in Eupraxia Pharmaceuticals Inc (TSX:EPRX) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Eupraxia Pharmaceuticals Inc is the acquisition of 400 shares on March 31, 2023, which cost Amanda Michelle Malone around $164,400.

Insider Trading History of Amanda Michelle Malone

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Amanda Michelle Malone Trading Performance

GuruFocus tracks the stock performance after each of Amanda Michelle Malone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amanda Michelle Malone is 69.24%. GuruFocus also compares Amanda Michelle Malone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amanda Michelle Malone within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Amanda Michelle Malone's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Amanda Michelle Malone

Average Return

Average return per transaction

Outperforming Transactions

6 out of 7 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	35.51
Relative Return to S&P 500(%)	33.78

Amanda Michelle Malone Ownership Network

Ownership Network List of Amanda Michelle Malone

No Data

Ownership Network Relation of Amanda Michelle Malone

Amanda Michelle Malone Owned Company Details

What does Eupraxia Pharmaceuticals Inc do?

Who are the key executives at Eupraxia Pharmaceuticals Inc?

Amanda Michelle Malone is the Senior Officer of Eupraxia Pharmaceuticals Inc. Other key executives at Eupraxia Pharmaceuticals Inc include Senior Officer Paul Anthony Brennan , Director or Senior Officer of 10% Security Holder James Besser , and Director or Senior Officer of 10% Security Holder Morgan Frank .

Eupraxia Pharmaceuticals Inc (TSX:EPRX) Insider Trades Summary

Over the past 18 months, Amanda Michelle Malone made no insider transaction in Eupraxia Pharmaceuticals Inc (TSX:EPRX). Other recent insider transactions involving Eupraxia Pharmaceuticals Inc (TSX:EPRX) include a net purchase of 3,800 shares made by Michael Wilmink ,

In summary, during the past 3 months, insiders sold 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) in total and bought 1,900 shares, with a net purchase of 1,900 shares. During the past 18 months, 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) were sold and 3,800 shares were bought by its insiders, resulting in a net purchase of 3,800 shares.

Eupraxia Pharmaceuticals Inc (TSX:EPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eupraxia Pharmaceuticals Inc Insider Transactions

No Available Data

Amanda Michelle Malone Mailing Address

Above is the net worth, insider trading, and ownership report for Amanda Michelle Malone. Currently GuruFocus does not have mailing address information for Amanda Michelle Malone.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.